Omada Hypertension Program for Hypertension

Phase-Based Progress Estimates

Effectiveness

Safety

Stanford University, Redwood City, CA

Hypertension

Omada Hypertension Program - Other

You have a chance of qualifying for this trial. We made sure your application will take less than 5 minutes.

Eligibility

18+

All Sexes

What conditions do you have?

Select

Eligibility

18+

All Sexes

What conditions do you have?

Select

Study Summary

High blood pressure, also known as hypertension, affects nearly half of all Americans and increases the risk for heart disease and stroke. Only about half of people with high blood pressure have it under control. New methods to control blood pressure are needed to reduce heart attack and stroke rates. The purpose of this study is to test whether a digital program that includes personalized health coaching and remote patient monitoring with a connected blood pressure cuff, all delivered on a smartphone or website, can improve blood pressure control compared with usual care among patients with high blood pressure.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Hypertension

Enalapril Pill

A first, then B

Kaiser Bundle

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: Baseline, 1 year

Baseline, 1 year

Mean change from baseline in A1c at 1-year

Mean change from baseline in systolic blood pressure at 1-year

Mean change from baseline in weight at 1-year

Trial Safety

Safety Progress

1 of 3

Other trials for Hypertension

Enalapril Pill

A first, then B

Kaiser Bundle

Trial Design

2 Treatment Groups

Does not receive access to Omada Health program

1 of 2

Receives access to Omada Health program

1 of 2

Active Control

Experimental Treatment

550 Total Participants · 2 Treatment Groups

Primary Treatment: Omada Hypertension Program · No Placebo Group · N/A

Receives access to Omada Health program

Other

Experimental Group · 1 Intervention: Omada Hypertension Program · Intervention Types: Other

Does not receive access to Omada Health programNoIntervention Group · 1 Intervention: Does not receive access to Omada Health program · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline

Screening: ~3 weeks

Treatment: Varies

Reporting: baseline, 1 year

Closest Location: Stanford University · Redwood City, CA

1992First Recorded Clinical Trial

24 TrialsResearching Hypertension

768 CompletedClinical Trials

Who is running the clinical trial?

Stanford UniversityLead Sponsor

2,130 Previous Clinical Trials

35,668,360 Total Patients Enrolled

30 Trials studying Hypertension

48,263 Patients Enrolled for Hypertension

Omada Health, Inc.Industry Sponsor

4 Previous Clinical Trials

1,052 Total Patients Enrolled

Steven Lin, MDPrincipal InvestigatorStanford University

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

You are at least 18 years old.

About The Reviewer

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References